Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Olopatadine Hydrochloride Patent Expiration

Olopatadine Hydrochloride is Used for treating allergic conjunctivitis and relieving ocular itching associated with allergic conjunctivitis. It was first introduced by Alcon Laboratories Inc in its drug Pataday Twice Daily Relief on Dec 18, 1996. Other drugs containing Olopatadine Hydrochloride are Pataday Once Daily Relief, Patanase. 21 different companies have introduced drugs containing Olopatadine Hydrochloride.


Olopatadine Hydrochloride Patents

Given below is the list of patents protecting Olopatadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pataday Once Daily Relief US8791154 High concentration olopatadine ophthalmic composition May 19, 2032 Alcon Labs Inc
Pataday Once Daily Relief US9533053 High concentration olopatadine ophthalmic composition May 19, 2032 Alcon Labs Inc
Pataday Once Daily Relief US6995186

(Pediatric)

 Olopatadine formulations for topical administration May 12, 2024

(Expired)

 Alcon Labs Inc
Pataday Once Daily Relief US6995186 Olopatadine formulations for topical administration Nov 12, 2023

(Expired)

 Alcon Labs Inc
Patanase US7977376

(Pediatric)

 Olopatadine formulations for topical nasal administration Aug 02, 2023

(Expired)

 Novartis
Patanase US8399508

(Pediatric)

 Olopatadine formulations for topical nasal administration Mar 17, 2023

(Expired)

 Novartis
Patanase US7977376 Olopatadine formulations for topical nasal administration Feb 02, 2023

(Expired)

 Novartis
Pataday Once Daily Relief US7402609

(Pediatric)

 Olopatadine formulations for topical administration Dec 19, 2022

(Expired)

 Alcon Labs Inc
Patanase US8399508 Olopatadine formulations for topical nasal administration Sep 17, 2022

(Expired)

 Novartis
Pataday Once Daily Relief US7402609 Olopatadine formulations for topical administration Jun 19, 2022

(Expired)

 Alcon Labs Inc
Pataday Once Daily Relief US5641805

(Pediatric)

 Topical ophthalmic formulations for treating allergic eye diseases Dec 06, 2015

(Expired)

 Alcon Labs Inc
Pataday Twice Daily Relief US5641805

(Pediatric)

 Topical ophthalmic formulations for treating allergic eye diseases Dec 06, 2015

(Expired)

 Alcon Labs Inc
Pataday Once Daily Relief US5641805 Topical ophthalmic formulations for treating allergic eye diseases Jun 06, 2015

(Expired)

 Alcon Labs Inc
Pataday Twice Daily Relief US5641805 Topical ophthalmic formulations for treating allergic eye diseases Jun 06, 2015

(Expired)

 Alcon Labs Inc



Olopatadine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Olopatadine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Olopatadine Hydrochloride. The first generic version for Olopatadine Hydrochloride was by Apotex Inc and was approved on Oct 8, 2014. And the latest generic version is by Glenmark Pharmaceuticals Inc Usa and was approved on Feb 28, 2025.

Given below is the list of companies who have filed for Olopatadine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 7, 2018
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Apr 29, 2019


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Vadodara Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Vadodara Alembic Pharmaceuticals Ltd





2. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.665MG/SPRAY

(reference standard)

spray, metered Prescription NASAL AB Jan 28, 2020


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Brookhaven Amneal Pharmaceuticals of New York, LLC
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Branchburg Amneal Pharmaceuticals, LLC
Glasgow Amneal Pharmaceuticals LLC
Piscataway Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Bridgewater Amneal Complex Products Research LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Hyderabad Amneal Oncology Private Limited





3. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 7, 2015
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 5, 2017


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





4. APOTEX INC

Apotex Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.665MG/SPRAY

spray, metered Prescription NASAL AB Oct 8, 2014


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
North York Apotex Inc.





5. BARR LABS INC

Barr Laboratories Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Jul 13, 2015





6. BAUSCH AND LOMB INC

Bausch And Lomb Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bausch And Lomb Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Jul 26, 2017
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 5, 2017





7. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 18, 2015
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Apr 4, 2019


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited





8. FDC LTD

Fdc Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Fdc Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Discontinued OPHTHALMIC N/A Sep 26, 2019





9. FLORIDA

Florida Pharmaceutical Products Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Florida.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.7% BASE

solution/drops Discontinued OPHTHALMIC N/A Feb 19, 2020





10. GLAND

Gland Pharma Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Aug 2, 2019
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A May 20, 2020


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited
Sriperumbudur Gland Chemical Private Limited
Malur Gland Chemicals Pvt Ltd.
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Aurangabad Gland Chemical Private Limited
Visakhapatnam Gland Pharma Limited
Parawada, Visakhapatnam Gland Pharma Limited





11. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Jun 28, 2017
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Feb 28, 2025





12. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.665MG/SPRAY

spray, metered Discontinued NASAL N/A Aug 19, 2020


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





13. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.665MG/SPRAY

spray, metered Prescription NASAL AB Jan 31, 2017


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





14. RISING

Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Mar 21, 2018
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Jun 16, 2020


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Fort Bragg Rising Tide Sea Vegetables
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Saddle Brook Rising Pharmaceuticals, Inc.
Mount Morris Rising Creek Bakery LLC
East Brunswick Rising Pharma Holding, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Decatur Rising Pharma Holdings, Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





15. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Discontinued OPHTHALMIC N/A Jan 10, 2017
EQ 0.2% BASE

solution/drops Discontinued OPHTHALMIC N/A Dec 5, 2017





16. SOMERSET

Somerset Therapeutics Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.2% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 18, 2024


Manufacturing Plant Locations
New

Somerset's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Somerset as present at those locations.

Country City Firm Name
United States
Fairfield Somerset Auction Company, LLC
Somerville Somerset Medical Center IRB
India
Bengaluru Somerset Therapeutics Limited





17. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 7, 2015





18. USV

Usv Private Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Usv.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Over the counter OPHTHALMIC N/A Dec 7, 2015


Manufacturing Plant Locations
New

Usv's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Usv as present at those locations.

Country City Firm Name
India
Mumbai USV Private Limited
Daman USV Private Limited
Takula Khed, Dist. Ratnagiri USV Private Limited





19. ZAMBON SPA

Zambon Spa has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zambon Spa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.1% BASE

solution/drops Discontinued OPHTHALMIC N/A Dec 7, 2015